Report Detail
Global (United States, European Union and China) Bladder Cancer Treatment Drugs Market Research Report 2019-2025
- RnM3653991 |
- 07 August, 2019 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
Bladder cancer refers to the growth of abnormal tissues in the lining of the bladder. These abnormal tissues are referred to as tumor, which even spread in the surrounding tissues or muscles.
The increase in prevalence of bladder cancer, advanced health care services, technological advancements, drug innovations with regard to the treatment of this cancer for ex launch of EOquin, and government initiatives could contribute to the growth of the bladder cancer treatment drugs market. Majority of bladder cancer patients are over the age of 60. Rise in the geriatric population is anticipated to drive the market growth. Additionally, growing awareness about bladder diseases, therapies available in the market, and increasing health care expenditure are significantly contributing toward the growth of the global bladder cancer treatment drugs market. However, rise in number of patent expirations, increase in use of generic drugs, and asymptomatic nature of the disease are some major factors that could hamper the growth of the market.
North America dominates the bladder cancer treatment drugs market followed by Europe. Rise in bladder cancer cases, availability of advanced health care solutions, developed health care infrastructure, and growing concern regarding the disease in these regions are key factors attributed to the significant market share. However, rapidly increasing prevalence of bladder cancer in the Asia Pacific region, in which India being the major country having large number of patients suffering from this disease, is expected to experience a high growth rate in the bladder cancer treatment drugs market over the forecast period. Further, increasing awareness about cancer diagnosis, growing demand for improved bladder cancer treatments and therapies, developing health care infrastructure, and rising health care expenditure in the region can drive the market growth.
In 2019, the market size of Bladder Cancer Treatment Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Bladder Cancer Treatment Drugs.
This report studies the global market size of Bladder Cancer Treatment Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Bladder Cancer Treatment Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Pfizer
GlaxoSmithKline
Celgene Corporation
Sanofi
Hoffmann-La Roche
Novartis International
Eli Lilly
AstraZeneca
Bristol-Myers Squibb
Market Segment by Product Type
Non-Muscle-Invasive Bladder Cancer
Muscle-Invasive Bladder Cancer
Market Segment by Application
Low-Grade Tumors
High-Grade Tumors
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Bladder Cancer Treatment Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Bladder Cancer Treatment Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Bladder Cancer Treatment Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Bladder Cancer Treatment Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Non-Muscle-Invasive Bladder Cancer
- 1.3.3 Muscle-Invasive Bladder Cancer
- 1.4 Market Segment by Application
- 1.4.1 Global Bladder Cancer Treatment Drugs Market Share by Application (2019-2025)
- 1.4.2 Low-Grade Tumors
- 1.4.3 High-Grade Tumors
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Bladder Cancer Treatment Drugs Market Size
- 2.1.1 Global Bladder Cancer Treatment Drugs Revenue 2014-2025
- 2.1.2 Global Bladder Cancer Treatment Drugs Sales 2014-2025
- 2.2 Bladder Cancer Treatment Drugs Growth Rate by Regions
- 2.2.1 Global Bladder Cancer Treatment Drugs Sales by Regions 2014-2019
- 2.2.2 Global Bladder Cancer Treatment Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Bladder Cancer Treatment Drugs Sales by Manufacturers
- 3.1.1 Bladder Cancer Treatment Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Bladder Cancer Treatment Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Bladder Cancer Treatment Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Bladder Cancer Treatment Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Bladder Cancer Treatment Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 Bladder Cancer Treatment Drugs Price by Manufacturers
- 3.4 Key Manufacturers Bladder Cancer Treatment Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Bladder Cancer Treatment Drugs Market
- 3.6 Key Manufacturers Bladder Cancer Treatment Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Non-Muscle-Invasive Bladder Cancer Sales and Revenue (2014-2019)
- 4.1.2 Muscle-Invasive Bladder Cancer Sales and Revenue (2014-2019)
- 4.2 Global Bladder Cancer Treatment Drugs Sales Market Share by Type
- 4.3 Global Bladder Cancer Treatment Drugs Revenue Market Share by Type
- 4.4 Bladder Cancer Treatment Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Bladder Cancer Treatment Drugs Sales by Application
6 United States
- 6.1 United States Bladder Cancer Treatment Drugs Breakdown Data by Company
- 6.2 United States Bladder Cancer Treatment Drugs Breakdown Data by Type
- 6.3 United States Bladder Cancer Treatment Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union Bladder Cancer Treatment Drugs Breakdown Data by Company
- 7.2 European Union Bladder Cancer Treatment Drugs Breakdown Data by Type
- 7.3 European Union Bladder Cancer Treatment Drugs Breakdown Data by Application
8 China
- 8.1 China Bladder Cancer Treatment Drugs Breakdown Data by Company
- 8.2 China Bladder Cancer Treatment Drugs Breakdown Data by Type
- 8.3 China Bladder Cancer Treatment Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Bladder Cancer Treatment Drugs Breakdown Data by Company
- 9.2 Rest of World Bladder Cancer Treatment Drugs Breakdown Data by Type
- 9.3 Rest of World Bladder Cancer Treatment Drugs Breakdown Data by Application
- 9.4 Rest of World Bladder Cancer Treatment Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Bladder Cancer Treatment Drugs Sales by Countries
- 9.4.2 Rest of World Bladder Cancer Treatment Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Pfizer
- 10.1.1 Pfizer Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Bladder Cancer Treatment Drugs
- 10.1.4 Bladder Cancer Treatment Drugs Product Introduction
- 10.1.5 Pfizer Recent Development
- 10.2 GlaxoSmithKline
- 10.2.1 GlaxoSmithKline Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Bladder Cancer Treatment Drugs
- 10.2.4 Bladder Cancer Treatment Drugs Product Introduction
- 10.2.5 GlaxoSmithKline Recent Development
- 10.3 Celgene Corporation
- 10.3.1 Celgene Corporation Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Bladder Cancer Treatment Drugs
- 10.3.4 Bladder Cancer Treatment Drugs Product Introduction
- 10.3.5 Celgene Corporation Recent Development
- 10.4 Sanofi
- 10.4.1 Sanofi Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Bladder Cancer Treatment Drugs
- 10.4.4 Bladder Cancer Treatment Drugs Product Introduction
- 10.4.5 Sanofi Recent Development
- 10.5 Hoffmann-La Roche
- 10.5.1 Hoffmann-La Roche Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Bladder Cancer Treatment Drugs
- 10.5.4 Bladder Cancer Treatment Drugs Product Introduction
- 10.5.5 Hoffmann-La Roche Recent Development
- 10.6 Novartis International
- 10.6.1 Novartis International Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Bladder Cancer Treatment Drugs
- 10.6.4 Bladder Cancer Treatment Drugs Product Introduction
- 10.6.5 Novartis International Recent Development
- 10.7 Eli Lilly
- 10.7.1 Eli Lilly Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Bladder Cancer Treatment Drugs
- 10.7.4 Bladder Cancer Treatment Drugs Product Introduction
- 10.7.5 Eli Lilly Recent Development
- 10.8 AstraZeneca
- 10.8.1 AstraZeneca Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Bladder Cancer Treatment Drugs
- 10.8.4 Bladder Cancer Treatment Drugs Product Introduction
- 10.8.5 AstraZeneca Recent Development
- 10.9 Bristol-Myers Squibb
- 10.9.1 Bristol-Myers Squibb Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Bladder Cancer Treatment Drugs
- 10.9.4 Bladder Cancer Treatment Drugs Product Introduction
- 10.9.5 Bristol-Myers Squibb Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Bladder Cancer Treatment Drugs Sales Channels
- 11.2.2 Bladder Cancer Treatment Drugs Distributors
- 11.3 Bladder Cancer Treatment Drugs Customers
12 Market Forecast
- 12.1 Global Bladder Cancer Treatment Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global Bladder Cancer Treatment Drugs Sales Forecast by Type
- 12.3 Global Bladder Cancer Treatment Drugs Sales Forecast by Application
- 12.4 Bladder Cancer Treatment Drugs Forecast by Regions
- 12.4.1 Global Bladder Cancer Treatment Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Bladder Cancer Treatment Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Bladder Cancer Treatment Drugs. Industry analysis & Market Report on Bladder Cancer Treatment Drugs is a syndicated market report, published as Global (United States, European Union and China) Bladder Cancer Treatment Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Bladder Cancer Treatment Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
